Page last updated: 2024-08-22

hydrocortisone-17-butyrate and Dermatitis, Irritant

hydrocortisone-17-butyrate has been researched along with Dermatitis, Irritant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bieber, T; Bos, JD; Cambazard, F; Fabbri, P; Fölster-Holst, R; Groenhoej Larsen, C; Ortonne, JP; Reitamo, S; Sand, C; Vena, G1

Trials

1 trial(s) available for hydrocortisone-17-butyrate and Dermatitis, Irritant

ArticleYear
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    The British journal of dermatology, 2005, Volume: 152, Issue:6

    Topics: Adult; Chi-Square Distribution; Dermatitis, Atopic; Dermatitis, Irritant; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids; Herpes Simplex; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Ointments; Sample Size; Statistics, Nonparametric; Tacrolimus; Time Factors; Treatment Outcome

2005